ONMD.NASDAQOnemednet CORP

Form 4: OneMedNet CEO Sells Shares for Tax Obligations

Sentiment:

Insider Transaction Report


OneMedNet Corp's CEO, Aaron Green, sold shares on two occasions in late 2025 to cover tax withholding obligations related to restricted stock unit awards.

Summary

  • Aaron Green, Chief Executive Officer and Director of OneMedNet Corp (ONMD), reported two transactions involving the sale of common stock.
  • On October 22, 2025, Green disposed of 64,767 shares of common stock at a price of $2.2345 per share.
  • On November 18, 2025, Green disposed of an additional 61,555 shares of common stock at a price of $1.2006 per share.
  • These sales were explicitly stated to be solely for the purpose of covering tax withholding obligations upon the vesting and settlement of restricted stock unit awards.
  • Following these reported transactions, Aaron Green's direct beneficial ownership of OneMedNet Corp common stock stands at 1,804,103 shares.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transaction is a routine, non-discretionary sale for tax purposes, which is a common occurrence for executives receiving equity compensation. It does not indicate a change in company fundamentals or management's outlook.

Positives

  • The sales were for a routine and non-discretionary purpose (tax withholding), which typically does not signal a lack of confidence in the company's future.
  • The CEO continues to hold a substantial number of shares (1,804,103), maintaining significant alignment with shareholder interests.

Negatives

  • A reduction in direct beneficial ownership by a key executive, even if for tax purposes, slightly decreases insider alignment.
  • The share price for the second transaction ($1.2006) was significantly lower than the first ($2.2345), indicating a decline in the stock price between the two sale dates.

Management Comments

  • "Represents shares sold solely to cover tax withholding obligations upon vesting and settlement of restricted stock unit awards."

Industry Context

This Form 4 filing details a routine insider transaction and does not provide broader industry context or trends. Such transactions are common across all industries when executives receive equity compensation.

Stakeholder Impact

  • Shareholders: A minor reduction in direct insider ownership, but the stated reason for the sale mitigates concerns about management confidence. The CEO retains a significant stake.
  • Employees: No direct impact mentioned.

Key Dates

DateDescription
10/22/2025Transaction date for the sale of 64,767 shares of common stock.
11/18/2025Transaction date for the sale of 61,555 shares of common stock.
12/23/2025Date the Form 4 was signed by Aaron Green.

Keywords

OneMedNet, ONMD, Form 4, Insider Trading, Stock Sale, CEO, Restricted Stock Units, Tax Withholding

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.